Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-18-016854
Filing Date
2018-09-11
Accepted
2018-09-11 16:30:21
Documents
22
Period of Report
2018-10-25
Effectiveness Date
2018-09-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tech20180906_def14a.htm DEF 14A 1282524
2 pc2.jpg GRAPHIC 155661
3 pc1.jpg GRAPHIC 174473
4 a7.jpg GRAPHIC 40589
5 a6.jpg GRAPHIC 68261
6 a5.jpg GRAPHIC 60059
7 d8.jpg GRAPHIC 4068
8 d7.jpg GRAPHIC 3988
9 d6.jpg GRAPHIC 3527
10 d5.jpg GRAPHIC 4266
11 d4.jpg GRAPHIC 3849
12 d3.jpg GRAPHIC 3638
13 d2.jpg GRAPHIC 4183
14 d1.jpg GRAPHIC 4195
15 a4.jpg GRAPHIC 133859
16 a3.jpg GRAPHIC 95561
17 a2.jpg GRAPHIC 12847
18 a1.jpg GRAPHIC 46244
19 sig2.jpg GRAPHIC 3583
20 banner.jpg GRAPHIC 17848
21 tech20180906_def14aimg002.jpg GRAPHIC 7111
22 sig.jpg GRAPHIC 3194
  Complete submission text file 0001437749-18-016854.txt   2457746
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-17272 | Film No.: 181065152
SIC: 2836 Biological Products, (No Diagnostic Substances)